Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

12 Feb 2010

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, says Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women's HealthSource.

12 Feb 2010

FDA grants approval for Abbott's antiretroviral medication Norvir

Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir ® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients.

11 Feb 2010

Study suggests obesity prevention efforts should begin much earlier

While many adults consider a chubby baby healthy, too many plump infants grow up to be obese teens, saddling them with Type-2 diabetes, elevated cholesterol and high blood pressure, according to an article published this month in the journal Clinical Pediatrics (published by SAGE).

11 Feb 2010

Daiichi Sankyo's Benicar receives FDA approval for hypertension treatment in children and adolescents aged 6-16

Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar® (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age. Benicar was originally approved in 2002 for the treatment of hypertension in adults.

11 Feb 2010

RadPharm and Medifacts International announce merger

RadPharm Inc., a leading Imaging Core Laboratory, and Medifacts International, Inc., a leading Cardiovascular Core Laboratory, today announced the merger of their business operations. The combined company will be named CoreLab Partners ("CoreLabs") and will have its corporate headquarters in Princeton, New Jersey.

11 Feb 2010

Barley beta-glucan soluble fiber lowers cholesterol and reduces risk for coronary heart disease

According to statistics from the Centers for Disease Control and Prevention, heart disease continues to be the leading cause of death in the United States and is also a major cause of disability. But the good news is improving heart health can be as easy as making simple lifestyle changes like choosing foods with proven heart health-promoting attributes.

11 Feb 2010

Current research underway to prevent preterm births

Family history, infection and stress all may play a role in raising a woman's risk of having a premature baby - but they don't fully explain why some women give birth too soon and others don't, according to a review article published today in the New England Journal of Medicine.

11 Feb 2010

Migraine sufferers face increase risk of heart attack, says study

People with migraine may be at an increased risk of heart attack and other risk factors for heart disease, according to a study published in the February 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Feb 2010

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

Geneva, situated at the heart of Europe, provides a fitting setting for the 10th Annual Spring Meeting of the European Society of Cardiology Council (ESC) on Cardiovascular Nursing and Allied Professionals (CCNAP), 12 - 13 March 2010, with its special theme: "Uniting to Improve Cardiovascular Practice".

11 Feb 2010

Study shows more women die of heart disease each year than men

Cardiovascular disease (commonly referred to as heart disease) is the leading cause of death for women worldwide. Almost every minute, a woman in the U.S. dies from heart disease. Despite the prevalence of heart disease in women, a 2005 American Heart Association study showed that 92% of primary care physicians and 83% of cardiologists were not aware of the fact that more women than men die of heart disease each year.

10 Feb 2010

Cardiac arrest due to medication-induced heart rhythm disturbance: Rare but catastrophic

Hospital care providers need to be more aware that cardiac arrest from a medication-induced heart rhythm problem is a rare but potentially catastrophic event in patients, according to a joint scientific statement from the American Heart Association and American College of Cardiology.

10 Feb 2010

Rating of risk factors associated with cardiovascular disease: Low IQ follows cigarette smoking

While lower intelligence scores - as reflected by low results on written or oral tests of IQ - have been associated with a raised risk of cardiovascular disease, no study has so far compared the relative strength of this association with other established risk factors such as obesity, smoking and high blood pressure. Now, a large study funded by Britain's Medical Research Council, which set out to gauge the relative importance of IQ alongside other risk factors, has found that lower intelligence scores were associated with higher rates of cardiovascular disease and total mortality at a greater level of magnitude than found with any other risk factor except smoking.

10 Feb 2010

Future studies may provide clarity on the best approach for pre-surgery beta blockers

In a commentary appearing in this week's Journal of the American Medical Association, heart specialists at the University of Michigan Health System make a plea for clarity on the best approach for prescribing beta blockers before surgery.

10 Feb 2010

Restricted fetal growth during first trimester linked to maternal high blood pressure and hematocrit levels

Factors such as maternal high blood pressure and high hematocrit levels (the proportion of blood that consists of red blood cells) are associated with a greater likelihood of restricted fetal growth during the first trimester, with restricted growth linked to an increased risk of preterm birth and low birth weight, according to a study in the February 10 issue of JAMA.

10 Feb 2010

Continua Certified USB-enabled platform now available for building agent healthcare devices

Texas Instruments Incorporated and S3 Group, a connected healthcare technology solutions company, today announced the availability of the first Continua Certified™ USB-enabled platform for building agent healthcare devices.

10 Feb 2010

NYBC calls for blood donation to meet winter needs

New York Blood Center (NYBC) serving New York City, Long Island, Hudson Valley and New Jersey calls upon the community to please donate blood and platelets, as the tri-state area braces for a huge predicted winter snowstorm. Healthy people of all blood types and ethnicities are encouraged to donate this week.

10 Feb 2010

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

The robotic system "enhances a doctor's natural ability, and we believe it will contribute to improved procedural outcomes," said Dr. David Wilber of Loyola University Health System, a nationally known researcher in heart rhythm disorders.

10 Feb 2010

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

10 Feb 2010

Early life stress could be a risk factor for cardiovascular disease in adulthood

"We think early life stress increases sensitivity to a hormone known to increase your blood pressure and increases your cardiovascular risk in adult life," said Dr. Jennifer Pollock, biochemist in the Vascular Biology Center at the Medical College of Georgia and corresponding author on the study published online in Hypertension.

10 Feb 2010

Blood Pressure News and Research

Further Reading

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

FDA grants approval for Abbott's antiretroviral medication Norvir

Study suggests obesity prevention efforts should begin much earlier

Daiichi Sankyo's Benicar receives FDA approval for hypertension treatment in children and adolescents aged 6-16

RadPharm and Medifacts International announce merger

Barley beta-glucan soluble fiber lowers cholesterol and reduces risk for coronary heart disease

Current research underway to prevent preterm births

Migraine sufferers face increase risk of heart attack, says study

10th Annual Spring Meeting of ESC on Cardiovascular Nursing and Allied Professionals

Study shows more women die of heart disease each year than men

Cardiac arrest due to medication-induced heart rhythm disturbance: Rare but catastrophic

Rating of risk factors associated with cardiovascular disease: Low IQ follows cigarette smoking

Future studies may provide clarity on the best approach for pre-surgery beta blockers

Restricted fetal growth during first trimester linked to maternal high blood pressure and hematocrit levels

Continua Certified USB-enabled platform now available for building agent healthcare devices

NYBC calls for blood donation to meet winter needs

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Early life stress could be a risk factor for cardiovascular disease in adulthood

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News